Prevalence of Bacterial Lower Respiratory Tract Infections at a Tertiary Hospital in Jordan
Keywords:lower respiratory tract infections, pneumonia, Jordan, Bacterial
Background: Lower respiratory tract infections (LRTI) are a major cause of morbidity and mortality globally. The World Health Organization (WHO) estimates that LRTI are the most common global cause of death from infectious diseases. However, the specific etiologic agent associated with LRTI is often unknown.
Aims: We determined the bacterial infections and seasonal patterns associated with LRTI among hospitalized cases at Jordan University Hospital (JUH) for a period of five years.
Methods: We conducted a multi-year study among hospitalized patients in Jordan on LRTI-associated bacterial etiology.
Results: We found bacterial infections among 105 (21.1%) out of 495 LRTI patients. The most frequently identified bacteria in the LRTI patients were Staphylococcus aureus (7.7%) followed by Pseudomonas aeruginosa (5.1%). Most of the LRTI patients (95.2%) had at least one chronic disease and many were admitted to the Intensive Care Unit (16.8%). Of the 18 (3.64%) patients with LRTI who died at the hospital, 2 had a bacterial infection. We noticed a seasonal pattern of bacterial infections, with the highest prevalence during the winter months.
Conclusions: Our findings suggest that early identification of bacterial agents and control of chronic disease may improve clinical management and reduce morbidity and mortality from LRTI.
Troeger C, Blacker B, Khalil IA, Rao PC, Cao J, Zimsen SR, et
al. Estimates of the global, regional, and national morbidity,
mortality, and aetiologies of lower respiratory infections in 195
countries, 1990-2016: a systematic analysis for the Global Burden
of Disease Study 2016. Lancet Infect Dis 2018; 18(11):1191-210.
File TM. Community-acquired pneumonia. Lancet 2003;
Gross AE, Van Schooneveld TC, Olsen KM, Rupp ME, Bui TH,
Forsung E, et al. Epidemiology and predictors of multidrugresistant
community-acquired and health care-associated
pneumonia. Antimicrob agents chemother 2014; 58(9):5262-8.
Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O'Brien
KL, Andreo F, et al. Estimating the burden of pneumococcal
pneumonia among adults: a systematic review and metaanalysis
of diagnostic techniques. PloS one 2013; 8(4):e60273.
Welte T, Torres A, Nathwani D. Clinical and economic burden
of community-acquired pneumonia among adults in Europe.
Thorax 2012; 67(1):71-9.
Woodhead M. Community-acquired pneumonia in Europe:
causative pathogens and resistance patterns. Eur Respir J Suppl
Peto L, Nadjm B, Horby P, Ngan TT, van Doorn R, Van Kinh
N, et al. The bacterial aetiology of adult community-acquired
pneumonia in Asia: a systematic review. Trans R Soc Trop Med
Hyg 2014; 108(6):326-37.
Al-Ali MK, Batchoun RG, Al-Nour TM. Etiology of communityacquired
pneumonia in hospitalized patients in Jordan. Saudi
med J 2006; 27(6):813-6.
Jean SS, Hsueh PR. High burden of antimicrobial resistance in
Asia. Int J Antimicrob Agents 2011; 37(4):291-5.
Johny M, Babelly M, Al-Benwan K, Udo EE. Antimicrobial
resistance in clinical isolates of Streptococcus pneumoniae in a
tertiary hospital in Kuwait, 1997-2007: Implications for empiric
therapy. J Infect Public Health 2010; 3(2):60-6.
Brown JS. Geography and the aetiology of community-acquired
pneumonia. Respirology (Carlton, Vic) 2009; 14(8):1068-71.
Hopstaken R, Muris J, Knottnerus J, Kester A, Rinkens P, Dinant
G. Contributions of symptoms, signs, erythrocyte sedimentation
rate, and C-reactive protein to a diagnosis of pneumonia in
acute lower respiratory tract infection. Br J Gen Pract 2003;
Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC
definitions for nosocomial infections, 1988. Am J infect control
Helbig JH, Uldum SA, LÃœck PC, Harrison TG. Detection of
Legionella pneumophila antigen in urine samples by the
BinaxNOW immunochromatographic assay and comparison
with both Binax Legionella Urinary Enzyme Immunoassay (EIA)
and Biotest Legionella Urin Antigen EIA. J Med Microbiol 2001;
Andreo F, DomÃnguez J, Ruiz J, Blanco S, Arellano E, Prat C, et
al. Impact of rapid urine antigen tests to determine the etiology
of community-acquired pneumonia in adults. Respiratory med
Thorpe TC, Wilson M, Turner J, DiGuiseppi J, Willert M, Mirrett S,
et al. BacT/Alert: an automated colorimetric microbial detection
system. J clin microbiol 1990; 28(7):1608-12.
Aydemir O, Aydemir Y, Ozdemir M. The role of multiplex PCR
test in identification of bacterial pathogens in lower respiratory
tract infections. Pak J Med Sci 2014; 30(5):1011-6.
Lim W, Van der Eerden M, Laing R, Boersma W, Karalus N, Town
G, et al. Defining community acquired pneumonia severity
on presentation to hospital: an international derivation and
validation study. Thorax 2003; 58(5):377-82.
Howell MD, Donnino MW, Talmor D, Clardy P, Ngo L, Shapiro NI.
Performance of severity of illness scoring systems in emergency
department patients with infection. Acad Emerg Med 2007;
Committee BTSSoC. BTS guidelines for the management
of community acquired pneumonia in adults. Thorax 2001;
Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund
J. Etiology of community-acquired pneumonia: increased
microbiological yield with new diagnostic methods. Clin Infect
Dis 2010; 50(2):202-9.
Almaaytah A, Mukattash TL, Hajaj J. Dispensing of nonprescribed
antibiotics in Jordan. Patient preferadherence 2015;
Al-Lahham A, Qayyas JA, van der Linden M. The Impact of the
-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal
Carriage of Streptococcus pneumoniae in Infants of Ajlun
Governorate in Jordan. Jordan J Biol Sci 2018; 11(2).
Hayes BH, Haberling DL, Kennedy JL, Varma JK, Fry AM, Vora
NM. Burden of pneumonia-associated hospitalizations: United
States, 2001-2014. Chest 2018; 153(2):427-37.
Shah BA, Singh G, Naik MA, Dhobi GN. Bacteriological and
clinical profile of Community acquired pneumonia in hospitalized
patients. Lung India: official organ of Indian Chest Society 2010;
Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa
J, et al. Etiology of community-acquired pneumonia: impact of
age, comorbidity, and severity. Am J Respir Crit Care Med 1999;
Run Sigurethardottir N, Nielsen AB, Munck A, Bjerrum L.
Appropriateness of antibiotic prescribing for upper respiratory
tract infectionsin general practice: Comparison between
Denmark and Iceland. Scand J Prim Health Care 2015;
Lubna Y. ALjaafreha MT, Asem A. Shehabi. Otitis External
Infections Among Jordanian Patients with Emphasis on
Pathogenic Characteristics of Pseudomonas Aeruginosa Isolates.
The Open Microbiol J. 2019; 13:3-7.
Shehabi AA, Shishtawi NI, Al-lawama M. Intestinal colonization
of infants with multidrug resistant Pseudomonas aeruginos in
tertiary care center in Jordan. The International Arabic Journal
of Antimicrobial Agents 2019; 9(2)
Alsayed AR, Alzihlif M, Al Ramahi JAW. Relevance of vancomycin
suceptibility on patients outcome infected with Staphylococcus
aureus. The International Arabic Journal of Antimicrobial Agents
Al Ghizawi G, Al Sulami A, Al Taher S. Profile of communityand
hospital-acquired pneumonia cases admitted to Basra
General Hospital, Iraq. East Mediterr Health J 2007 Mar-Apr;
Herrera-Lara S, Fernandez-Fabrellas E, Cervera-Juan A, Blanquer-
Olivas R. Do seasonal changes and climate influence the etiology
of community acquired pneumonia? Arch Bronconeumol 2013;
Mongardon N, Max A, BouglÃ© A, PÃ¨ne F, Lemiale V, Charpentier
J, et al. Epidemiology and outcome of severe pneumococcal
pneumonia admitted to intensive care unit: a multicenter study.
Critcare 2012; 16(4):R155.
Cordoba E, Maduro G, Huynh M, Varma JK, Vora NM, editors.
Deaths from pneumonia-New York City, 1999-2015. Open
Forum Infect Dis 2018 Jan 16; 5(2):ofy020.
Du P, Du R, Ren W, Lu Z, Fu P. Seasonal variation characteristic of
inhalablemicrobial communities in PM2. 5 in Beijing city, China.
Sci Total Environ 2018; 610:308-15.
Cilloniz C, Ewig S, Gabarrus A, Ferrer M, Puig de la Bella Casa
J, Mensa J, et al. Seasonality of pathogens causing communityacquired
pneumonia. Respirology 2017; 22(4):778-85.
Bsisu I, Obeidat Z, Ababneh N, Altous M, Obeidat M, Amer M,
et al. The etiology of viral lower respiratory tract infections at
a tertiary hospital in Jordan over five years. The International
Arabic Journal of Antimicrobial Agents 2019; 9(2)
Hageman JC, Uyeki TM, Francis JS, Jernigan DB, Wheeler JG,
Bridges CB, et al. Severe community-acquired pneumonia due
to Staphylococcus aureus, 2003-04 influenza season. Emerging
infect dis. 2006; 12(6):894.
Kallen AJ, Brunkard J, Moore Z, Budge P, Arnold KE, Fosheim G,
et al. Staphylococcus aureus community-acquired pneumonia
during the 2006 to 2007 influenza season. Ann Emerg Med
Altous M, Bsisu I, Obeidat Z, Ababneh N, Obeidat M, Amer M,
et al., editors. Viral lower respiratory tract infections requiring
hospitalisation among jordanian adults. Respirology 2019:
WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
Reed C, Kallen AJ, Patton M, Arnold KE, Farley MM, Hageman
J, et al. Infection with community-onset Staphylococcus aureus
and influenza virus in hospitalized children. Pediatr Infect Dis J
Finelli L, Fiore A, Dhara R, Brammer L, Shay DK, Kamimoto L, et
al. Influenza-associated pediatric mortality in the United States:
increase of Staphylococcus aureus coinfection. Pediatrics 2008;
Ishiguro T, Takayanagi N, Yamaguchi S, Yamakawa H, Nakamoto
K, Takaku Y, et al. Etiology and factors contributing to the severity
and mortality of community-acquired pneumonia. Intern med
; 52(3):317-24 Total Welte T, Marre R, Suttorp N. What is
new in the treatment of community-acquired pneumonia? Med
Klin (Munich) 2006; 101(4):313-20.
Yende S, Angus DC, Ali IS, Somes G, Newman AB, Bauer D,
et al. Influence of comorbid conditions on long-term mortality
after pneumonia in older people. J Am Geriatr Soc 2007;
Feikin DR, Hammitt LL, Murdoch DR, Oâ€™brien KL, Scott JAG.
The enduring challenge of determining pneumonia etiology in
children: considerations for future research priorities. Clin infect
dis 2017; 64(suppl_3):S188-S96.
Martens P, Worm SW, Lundgren B, Konradsen HB, BenfieldT.
Serotype-specific mortality from invasive Streptococcus
pneumoniae disease revisited. BMC infect dis 2004; 4(1):21.
Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa
J, et al. Etiology of community-acquired pneumonia: impact of
age, comorbidity, and severity. Am J respir crit care med 1999;
Weinberger B, Grubeck-Loebenstein B. Vaccines for the elderly.
Clin Microbiol Infect 2012; 18:100-8.
Walters JA, Tang JNQ, Poole P, Wood-Baker R. Pneumococcal
vaccines for preventing pneumonia in chronic obstructive
pulmonary disease. Cochrane Database Syst Rev 2017 Jan 24;
Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM,
et al. Community-acquired pneumonia requiring hospitalization
among US adults. N Engl J Med2015; 373(5):415-27.
Johnstone J, Majumdar SR, Fox JD, Marrie TJ. Viral infection
in adults hospitalized with community-acquired pneumonia:
prevalence, pathogens, and presentation. CHEST J 2008;
Lieberman D, Shimoni A, Shemer-Avni Y, Keren-Naos A,
Shtainberg R, Lieberman D. Respiratory viruses in adults with
community-acquired pneumonia. CHEST J 2010; 138(4):811-6.
Charles PG, Whitby M, Fuller AJ, Stirling R, Wright AA, Korman
TM, et al. The etiology of community-acquired pneumonia in
Australia: why penicillin plus doxycyclineor a macrolide is the
most appropriate therapy. Clin Infect Dis 2008; 46(10):1513-21.
Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman
WA, van den Broek PJ, Claas EC. Improved diagnosis of the
etiology of community-acquired pneumonia with real-time
polymerase chain reaction. Clin infect dis 2005; 41(3):345-51.
Wunderink RG, Waterer GW. Community-acquired pneumonia.
N Engl J Med 2014; 370(6):543-51.
Musher DM, Thorner AR. Community-acquiredpneumonia. N
Engl J Med2014; 371(17):1619-28.
Steinman MA, Gonzales R, Linder JA, Landefeld C. CHanging
use of antibiotics in community-based outpatient practice, 1991-
Ann Intern Med 2003; 138(7):525-33. doi: 10.7326/0003-
Kaplan V, Clermont G, Griffin MF, Kasal J, Watson RS, Linde-
Zwirble WT, et al. Pneumonia: still the old man's friend? Arch
Intern Med. 2003; 163(3):317-23.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Articles are published Under License of Creative Commons Attribution 3.0 License Â©
Copyright policies & self-archiving
|Author's Pre-print:||author can archive pre-print (ie pre-refereeing)|
|Author's Post-print:||author can archive post-print (ie final draft post-refereeing)|
|Publisher's Version/PDF:||author can archive publisher's version/PDF|